Quarterly report pursuant to Section 13 or 15(d)

Net Loss Per Share (Details) - Schedule of diluted net loss per share

v3.21.2
Net Loss Per Share (Details) - Schedule of diluted net loss per share - shares
 3 Months Ended 6 Months Ended
Mar. 31, 2021
Mar. 31, 2020
Jun. 30, 2021
Jun. 30, 2020
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]        
Total common stock equivalents 881,308 1,060,576 881,308 1,060,576
Stock options [Member]        
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]        
Total common stock equivalents 118,388 233,567 118,388 233,567
Warrants [Member]        
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]        
Total common stock equivalents 762,920 827,009 762,920 827,009